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W
hen and where a gene is ex-
pressed depends on its associ-
ated regulatory elements, chro-
matin environment, transcription factors, 
and numerous other infl  uences that scien-
tists do not yet fully understand. Because 
each gene has a particular expression pat-
tern, it can be diffi  cult to identify general 
rules for the switching on or off of genes.
Tae Hoon Kim is not perturbed by the 
diffi   culties. Although he started out 
studying regulation of one particular 
gene—interferon  (1), he quickly got a 
taste for taking his regulation studies ge-
nome wide. As a postdoc with Bing Ren, 
Kim used ChIP on 
chip (Chromatin im-
munoprecipitation on 
microarrays) to map 
the promoters of 
nearly 8,000 genes in 
the human genome 
(2). He then did a 
similar large-scale 
mapping project for 
potential insulator el-
ements, which form 
boundaries to the spread of hetero- or eu-
chromatin (3). He has also contributed to 
the Encyclopedia of DNA elements (EN-
CODE)—a project to identify all function-
al elements in the human genome (4).
Kim now runs his own laboratory at 
Yale, where he is particularly concerned 
with investigating gene regulatory pertur-
bations associated with cancer.
YOUNG STARTER
Where did you grow up?
I was born in Seoul, Korea, and lived there 
until I was 12. Then I came here to the States. 
My parents initially settled down in Los An-
geles, so I went to grammar school there and 
started junior high. Then we moved to Fres-
no, California, where I fi  nished high school.
What was it like moving over from 
Korea to the US?
I didn’t speak any English when I came 
here. And I hadn’t been a very good student 
in Korea. I was more interested in playing 
baseball. My mom was always pulling me 
back home from the baseball fi  eld to make 
me do my homework. She also had to visit 
the school several times to talk to the teach-
ers because I had problems.
But moving to the States, things 
changed dramatically. The schools are 
quite different. And I was also probably 
becoming a bit more mature.
How do the US and Korean schools 
compare?
The class sizes are smaller here in the 
States, so there’s more attention given to 
students. In elementary school in Korea I 
was in classes with 70 students. So it’s more 
factory style. They do a really good job, set-
ting a high standard for a large number of 
students. But if a student doesn’t fi  t the 
mold, they might fall through the cracks.
When did your interest in science begin?
I think I can give a large amount of credit 
for my scientifi  c career to my high school 
teacher, Tim Thomas. He wasn’t a science 
teacher, but he was responsible for stu-
dents participating in science projects. He 
motivated us to study independently. Be-
cause of him, I taught myself a lot of things 
that were outside of the high school cur-
riculum. I remember during my junior 
year, around age 16, he gave me a copy of 
Recombinant DNA; a textbook by Jim 
Watson. I was hooked. I went to the library 
and found Tom Maniatis’s Molecular 
Cloning: A Laboratory Manual. That was 
really inspirational because it had a whole 
rationale of how to do bench work.
It prompted me to set up a little molecu-
lar biology laboratory in the back room of 
the high school chemistry laboratory. I had 
a micro-centrifuge, and I built a couple of 
gel boxes. And I purchased some equip-
ment thanks to a mini-grant from the PTA.
Early practice for writing grant 
applications!
Yeah, now it’s a lot harder. I wish I didn’t 
have to write grants.
FROM GENE TO GENOME
Where did you go to college?
I attended Reed College in Portland, 
Oregon. It’s a small liberal arts college. 
I studied biology, and at one point I 
wrote an essay for one of my classes 
about a paper from the late 1960s by a 
famous microbiologist named Mark 
Ptashne. My professor pulled me aside 
and said, “Did you know Mark Ptashne 
went to Reed College?”
Then when I started at Harvard as a 
grad student, Mark Ptashne was actually 
still there. So I got some interesting ad-
vice from him early in my career.
And at Harvard you studied with Tom 
Maniatis.
Yes. And Maniatis had done his post-
doc with Mark Ptashne, so there’s a 
connection.
What did you study?
I worked on a large protein complex that 
controls gene expression called an en-
hanceosome. The particular enhanceo-
some I focused on regulates the interfer-
on  gene. I fi  gured out how the whole 
complex—approximately seven pro-
teins—assembled on DNA.
What made you switch from studying 
regulation of one gene to studying 
transcription at the genome-wide scale?
Soon after I started grad school, some papers 
came out about the technique of chromatin 
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immunoprecipitation. Tom’s laboratory was 
one of the fi  rst to apply this technique to hu-
man cells. Some people in the laboratory 
started looking at histone modifi  cations at 
the interferon locus. But Bing Ren, a gradu-
ate student in the laboratory who was four 
years ahead of me and who became my 
postdoc mentor later on, started to try ChIP 
cloning in yeast. He left Maniatis’s labora-
tory and joined Rick Young’s laboratory in 
order to develop the ChIP-chip technique, 
and then started his own laboratory.
After I graduated in 2002 I had several 
options of where to go, but I saw a lot of 
potential with Bing’s technique and with 
being in his laboratory. So we started talk-
ing and tried to fi  gure out how to apply his 
technique to the human genome. Our fi  rst 
human genome-wide paper from Bing’s 
laboratory came out in 2005.
We used antibodies against the preini-
tiation complex as a way of identifying 
promoters. It was a good way to test the 
system, as many promoters were well 
characterized. But even though it was a 
straightforward technical paper, it still 
gave us some unexpected results.
Such as?
There are a number of genes that have two 
or more alternative promoters. And in 
general it was thought that the different 
promoters are used in distinct cell types. 
But what we found in a large number of 
cases was that in fact genes would employ 
both promoters in the same cell type.
Have you got to the bottom of this 
inconsistency?
We have for one gene—a cell cycle regu-
lator. This gene has two promoters, and 
they seem to alternate depending on the 
cell cycle stage. So in a population of 
cells, activity from both promoters will be 
seen, but in each individual cell probably 
only one promoter will be active at a time, 
depending on the stage of the cell cycle. 
For other genes, though, we don’t know 
what might be responsible, so we still 
need to fi  gure out what’s going on.
So from genome-wide analyses you need 
to again bring your focus down to 
individual genes.
Yes, exactly.
BREAKING BOUNDARIES
What else are you working on?
We’re looking at large domains of hetero-
chromatin in cells. It’s known that an in-
sulator protein called CTCF marks the 
boundary where these domains stop. We 
have defi  ned these boundaries for more 
than 300 loci in the genome and are now 
trying to fi  gure out how they function.
These boundaries are interesting be-
cause if they are compromised somehow, 
for example in cancer cells, the hetero-
chromatin could spread to nearby genes, 
causing silencing.
Do such boundaries change in different 
cell types as well as in cancer?
They seem to be relatively stable, but there 
are some changes. For instance, if you look 
in fi  broblasts at the HoxA locus—a cluster 
of genes that show colinearity of expres-
sion and are important in development—
the spread of heterochromatin from the 3 
end to the 5 end of the cluster depends on 
where in the body the fi  broblasts  come 
from. Fibroblasts isolated from the upper 
body tend to have heterochromatin at the 
3 end of the HoxA locus, and fi  broblasts 
isolated from the foot tend to have the 5 
end heterochromatinized. Interestingly, 
though, the same bound-
ary is being used in the 
different fi  broblasts.
The boundary behav-
ior at this particular site 
seems to be distinct from 
most other insulators in 
the genome. So we’re try-
ing to work out what’s go-
ing on there, but also we’d 
like to know if there’s a 
general mechanism to 
boundary function.
How do you plan to 
study that?
By transposing the 
elements into a re-
porter system, we 
can analyze the nitty-
gritty details, manip-
ulate the sequence, 
and so on.
Are you working on 
any other projects?
We have a continu-
ing interest in en-
hancers, particularly 
ones that might play 
a critical role in cancers. So we have 
made some genome-wide maps of en-
hancers that are relevant for cancer. We 
found certain genes that are controlled 
by these classes of enhancers, and we’re 
trying to fi  gure out what the underlying 
mechanism is.
It seems that trying to ﬁ  nd unifying 
mechanisms for gene regulation is 
pretty tough.
It is. Usually, a grand theory gets pro-
posed, and then people basically fi  gure 
out all the contrary cases. I think that it’s 
really fun to be a contrarian, but it’s much 
harder to come up with grand theories. 
And I like a challenge, so I think I’m more 
of a lumper than a splitter.
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Kim has found that, although the boundary elements (blue) 
are the same in ﬁ  broblasts from the upper body (lung) as from 
the lower body (foot), the heterochromatin marks (red) are 
differently distributed.
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Kim uses ChIP on chip to look for gene 
regulatory elements in the human genome.
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